News Related to Cannabis Use Disorders

Related coverage linked through entity extraction aliases.

GLP-1 Drugs Show Protective Effects Against Addictions, Parkinson's, and Endometrial Cancer

Mar 05, 2026

New research reveals GLP-1 receptor agonists reduce substance use disorders by 14%, lower Parkinson's disease risk after 5-10 years of use, and cut endometrial cancer risk by 66% when combined with progestin therapy.

GLP-1 Medications Reduce Risk of Substance Use Disorders and Overdose Deaths, Study Finds

Mar 05, 2026

A large study of over 600,000 U.S. veterans with type 2 diabetes found GLP-1 medications reduced the risk of developing substance use disorders by 14% and cut drug-related deaths by 50% in those with existing addiction.